Pregnancy outcome following early exposure to maternal luteinizing-hormone-releasing hormone agonist (buserelin).
A human pregnancy exposed to a luteinizing-hormone-releasing hormone agonist (buserelin) in its early stages is reported. The possible mechanisms leading to conception under this mode of treatment and its consequences are discussed.
Dicker
D
D
Department of Obstetrics and Gynaecology, Golda Meir Medical Centre, Petah Tikva, Israel.
Goldman
J A
JA
Vagman
I
I
Eckstein
N
N
Ayalon
D
D
D000328:Adult; D002064:Buserelin / Q000494:pharmacology*; D005260:Female; D006801:Humans; D011247:Pregnancy / Q000187:drug effects*; D011256:Pregnancy Outcome
D002064:Buserelin